BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

eTheRNA

eTheRNA logo

Founded
2013
Geography
Belgium based
Funding
$74.734 M

eTheRNA immunotherapies' mission is to help patients to overcome certain cancers and infectious diseases by developing novel immunotherapies that target the fundamental role of dendritic cells in the human immune system. eTheRNA’s proprietary mRNA-based TriMix technology boosts dendritic cells leading to a more comprehensive, sustainable and safer enhancement of the patient’s immune system than any other similar approach investigated until now.


Posts Mentioning This Company

R&D Platform

-


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet